[Cefuroximaxetil: Effective and Cost Effective, From Respiratory Tract Infections to Lyme Disease. Proceedings from the 18th International Congress of Chemotherapy. Stockholm, 27 June-2 July 1993].
D000818:Animals; D002444:Cefuroxime / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy*; D011355:Prodrugs / Q000191:economics / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D011355:Prodrugs; D002444:Cefuroxime; C040738:cefuroxime axetil
Cefuroximaxetil: Effektiv und kostengünstig von Atemwegsinfektionen bis zur Lymeborreliose. Bericht vom 18. Internationalen Kongress für Chemotherapie. 27. Juni bis 2. Juli 1993 in Stockholm.